Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McMaster University

$135,000.00

Impact of cannabis smoke exposure on the respiratory mucosal response to viral infection as well as host mortality and morbidity

FY 2021-22

Summary
The United Nations World Drug Report estimates that over 180 million individuals use cannabis with 90% of users preferring smoking as a delivery route. Cannabis smokers have a higher incidence of coughing and chronic bronchitis relative to non-smokers, symptoms that are shared with tobacco smokers. Respiratory viral infections are more common in tobacco smokers, with greater influenza-related morbidity and mortality occurring in this population. Whether cannabis smokers are similarly susceptible to influenza infections remains unclear. This is important as influenza results in 250,000-500,000 global deaths annually. Our goal is to determine the impact of cannabis smoke on antiviral immunity and the mortality associated with viral infection. Using diverse cannabis strains available under a Health Canada approved license, we plan to expose human lung cells and animal models to cannabis smoke and assess their response to influenza A infection. Our approach will provide modern evidence to inform health policy, by defining the impact of cannabis smoke on antiviral responses as well as mortality risks associated with influenza A infection.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
454884
Name
Milad Nadia
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Health Research Training B - HP
Projecttitle
Impact of cannabis smoke exposure on the respiratory mucosal response to viral infection as well as host mortality and morbidity
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cannabis; Immunology; Influenza A; Mouse Models; Smoke Exposure; Viral Infection
Abstract
The United Nations World Drug Report estimates that over 180 million individuals use cannabis with 90% of users preferring smoking as a delivery route. Cannabis smokers have a higher incidence of coughing and chronic bronchitis relative to non-smokers, symptoms that are shared with tobacco smokers. Respiratory viral infections are more common in tobacco smokers, with greater influenza-related morbidity and mortality occurring in this population. Whether cannabis smokers are similarly susceptible to influenza infections remains unclear. This is important as influenza results in 250,000-500,000 global deaths annually. Our goal is to determine the impact of cannabis smoke on antiviral immunity and the mortality associated with viral infection. Using diverse cannabis strains available under a Health Canada approved license, we plan to expose human lung cells and animal models to cannabis smoke and assess their response to influenza A infection. Our approach will provide modern evidence to inform health policy, by defining the impact of cannabis smoke on antiviral responses as well as mortality risks associated with influenza A infection.
Competitiondate
202110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Milad, Nadia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~